Non-allergic rhinitis is more common than expected;Icke-allergisk rinit oväntat vanligt: Brokig skara tillstånd kan ge näsbesvär utan samtidig infektion eller allergi

Lakartidningen

Volumn 100, Issue 21, 2003, Pages 1897-1904

  Holmström, Mats ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; AZELASTINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOTULINUM TOXIN; CAPSAICIN; CHLORPROMAZINE; HYDRALAZINE; IPRATROPIUM BROMIDE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHYLDOPA; PROPRANOLOL; STEROID; ZILEUTON;

ARTICLE; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; HUMAN; PATHOGENESIS; PREVALENCE; RHINITIS; RISK FACTOR; TREATMENT OUTCOME; DRUG EFFECT; FEMALE; INNERVATION; MALE; NOSE MUCOSA; PATHOPHYSIOLOGY; PATIENT REFERRAL; REVIEW;

DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; NASAL MUCOSA; REFERRAL AND CONSULTATION; RHINITIS;

EID: 0344664510     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Hellgren J. Non-infectious rhinitis. Epidemiology and clinic [akademisk avhandling]. Göteborg: Sahlgrenska Universitetssjukhuset, Göteborgs Universitet; 2001
2. Leynaert B, Bousquet J, Neukirch C, Liard R, Neukirch F. Perennial rhinitis: an independent risk factor for asthma in non atopic subjects. J Allergy Clin Immunol 1999;104:301-4.
3. van Cauwenberge P, Bachert C, Passalacqua G, Bousquet J, Cannonica GW, Durham S, et al. Consensus statement on the treatment of allergic rhinitis. Allergy 2000;55:1-19.
4. Bousquet J, van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma (ARIA). J Allergy Clin Immunol 2001;108:147-334.
5. Lund VJ. Health related quality of life in sinonasal disease. Rhinology 2001;39:182-6.
6. European Allergy White Paper. Prevalence of allergic diseases. In: Epidemiology. Bruxelles: UCB Institute of Allergy;1997. p. 14-39.
7. Jessen M, Janzon L. Prevalence of non-allergic nasal complaints in an urban and a rural population in Sweden. Allergy 1989;44:582-7.
8. Mullarkey MF, Hill JS, Webb DR. Allergic and nonallergic rhinitis: their caracterization with attention to the meaning of nasal eosinophilia. J Allergy Clin Immunol 1980;65:122-6.
9. Stein MR. Does GERD affect rhinosinusitis? New York: American Academy of Allergy Asthma & Immunology; 2002.
10. Ellegård E. Pregnancy rhinitis [akademisk avhandling]. Göteborg: Sahlgrenska Universitetssjukhuset: Göteborgs Universitet; 1999.
11. Benninger MS. The impact of cigarette smoking and environmental tobacco smoke on nasal and sinus disease: a review of the literature. Am J Rhinology 1999;13:435-8.
12. Åhman M, Holmström M, Kolmodin-Hedman B, Thelin A. Nasal symptoms and patophysiology in farmers. Int Arch Occup Environ Health 2001;74:279-84.
13. Granstrand P, Nylander-French L, Holmström M. Biomarkers of nasal inflammation in wood-surface coating industry workers. Am J Ind Med 1998;33:392-9.
14. Holmström M, Rosén G, Wåhlander L. Effect of nasal lavage on nasal symptoms and physiology in wood industry workers. Rhinology 1997;35:108-12.
15. Cullen M. The worker with multiple chemical sensitivity: an overview. Occup Med 1987;2:655-2.
16. Sanico A, Togias A. Noninfectious, nonallergic rhinitis (NINAR): considerations on possible mechanisms. Am J Rhinology 1998;12:65-72.
17. Greiff L, Svensson C, Andersson M, Persson CG. Effects of topical capsaicin in seasonal allergic rhinitis. Thorax 1995;50:225-9.
18. Iguchi Y, Yao K, Okamoto M. A characteristic protein in nasal discharge differentiating non-allergic chronic rhinosinusitis from allergic rhinitis. Rhinology 2002;40:13-7.
19. Kondo H, Nachtigal D, Frenkiel S, Schotman E, Hamid O. Effects of steroids on inflammatory cells and cytokine profile. Laryngoscope 1999;109:91-7.
20. Lundblad L, Sipilä P, Farstad T, Drozdziewicz D. Mometasone furoate nasal spray in the treatment of perennial non-allergic rhinitis: a Nordic, multicenter, randomized, double-blind, placebo-controlled study. Acta Otolaryngol 2001;121:505-9.